سيجنيفور 0.6مجم/مل 30 امبول

indication for the treatment of cushingï-s disease specifically for those patients whom pituitary surgery has not been curative or is not an option. mechanism of action pasireotide activates a broad spectrum of somatostatin receptors exhbiting a much high